Physician profile
Allyson Snyder
NPI 1235722984
$1,269.50
in general payments reported to CMS, 2019-2025
22 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $362 · 2022: $269 · 2023: $195 · 2024: $171 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $638.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $191.96 | 2022-2023 | Xiaflex, Edex, Aveed |
| Convatec INC. | $174.09 | 2021-2022 | |
| 180 Medical, INC. | $149.76 | 2021-2022 | |
| Abbvie INC. | $131.87 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $116.08 | 2023-2025 | Calquence, Imfinzi |
| Astellas Pharma US INC | $75.60 | 2021-2025 | Xtandi |
| Merck Sharp & Dohme LLC | $72.06 | 2022-2025 | Keytruda, Welireg |
| Novartis Pharmaceuticals Corporation | $61.63 | 2022-2025 | |
| Janssen Biotech, INC. | $44.50 | 2022 | |
| Amgen INC. | $28.28 | 2022 | |
| Lilly USA, LLC | $25.59 | 2024 | Verzenio, Jaypirca, Retevmo |
| Pfizer INC. | $23.23 | 2024 | |
| Genzyme Corporation | $22.71 | 2022 | |
| Daiichi Sankyo INC. | $22.50 | 2022 | |
| Exelixis INC. | $21.07 | 2024 | Cabometyx |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $17.10 | 2024 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $17.03 | 2022 | |
| Caris Mpi, INC. | $16.70 | 2025 | Mi Cancer Seek |
| Eisai INC. | $16.37 | 2022 | |
| Mirati Therapeutics, INC. | $14.11 | 2023 | Krazati |
| Emd Serono, INC. | $13.64 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $13.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allyson Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.